Verdict Medical Devices

French ANSM authorises FineHeart’s device trial for heart failure

The French National Agency for the Safety of Medicines and Health Products (ANSM) has authorised FineHeart to commence a nonrandomised first-in-human trial in the country to assess the FlowMaker device in heart failure patients. The post French ANSM authorises FineHeart’s device trial for heart failure appeared first on Medical Device Network.

Jun 4, 2025 - 14:15
 0
French ANSM authorises FineHeart’s device trial for heart failure
The French National Agency for the Safety of Medicines and Health Products (ANSM) has authorised FineHeart to commence a nonrandomised first-in-human trial in the country to assess the FlowMaker device in heart failure patients.

The post French ANSM authorises FineHeart’s device trial for heart failure appeared first on Medical Device Network.

Read More

Tags:

Previous Article

Guardant Health’s MCD test earns FDA breakthrough designation

Next Article

EU votes to ‘freeze out’ China from medical device procurement in bloc

Related Posts

Neuralink secures $650m in Series E to advance brain implant technology

Neuralink secures $650m in Series E to advance brain im...

Jun 3, 2025  0

CU researchers develop test to measure mobility in lower-limb amputation

CU researchers develop test to measure mobility in lowe...

May 26, 2025  0

GE HealthCare and Kalbe open CT scanner production facility

GE HealthCare and Kalbe open CT scanner production faci...

Jun 3, 2025  0